USANA Health Sciences DEFA14A: Executive Compensation Details
Ticker: USNA · Form: DEFA14A · Filed: Apr 16, 2025 · CIK: 896264
| Field | Detail |
|---|---|
| Company | Usana Health Sciences Inc (USNA) |
| Form Type | DEFA14A |
| Filed Date | Apr 16, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, executive-compensation, equity-awards
TL;DR
USANA's proxy statement is out, showing exec comp details for FY24. Look out for equity award valuations.
AI Summary
USANA Health Sciences Inc. filed a DEFA14A on April 16, 2025, detailing executive compensation and related matters for the fiscal year ending December 28, 2024. The filing includes information on equity awards granted to individuals such as Mr. Brown and Mr. Guest, with data points for fiscal years 2021, 2022, and 2023. Specific details on the change in fair value of equity awards and outstanding awards are provided.
Why It Matters
This filing provides transparency into how USANA Health Sciences compensates its top executives, which can influence investor decisions and corporate governance.
Risk Assessment
Risk Level: low — This is a routine proxy filing detailing executive compensation and is not indicative of immediate financial risk.
Key Numbers
- 2024-12-28 — Fiscal Year End (The most recent fiscal year for which compensation details are provided.)
- 2023-12-31 — Fiscal Year End (Previous fiscal year for which compensation details are provided.)
- 2022-12-31 — Fiscal Year End (Previous fiscal year for which compensation details are provided.)
Key Players & Entities
- USANA HEALTH SCIENCES INC (company) — Filer of the DEFA14A
- Mr. Brown (person) — Executive mentioned in equity award details
- Mr. Guest (person) — Executive mentioned in equity award details
- SALT LAKE CITY (location) — City of USANA's business and mail address
FAQ
What is the primary purpose of this DEFA14A filing?
The primary purpose is to provide information regarding the solicitation of proxies for the company's annual meeting of shareholders, including details on executive compensation, director nominations, and other corporate governance matters.
Which fiscal years are covered by the compensation data in this filing?
The filing provides compensation data for fiscal years ending December 31, 2023, December 31, 2022, and January 1, 2023, with a focus on the fiscal year ending December 28, 2024.
Who are some of the individuals mentioned in relation to equity awards?
Individuals such as Mr. Brown and Mr. Guest are mentioned in the context of equity awards granted and outstanding.
What is the company's state of incorporation?
USANA Health Sciences Inc. is incorporated in Utah (UT).
What is the filing date of this DEFA14A?
This DEFA14A filing was made on April 16, 2025.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 16, 2025 by Mr. Brown regarding USANA HEALTH SCIENCES INC (USNA).